Research
Login
Sign Up
Home
Research
Sign Up
Home
Research Hub
FASTRACK II: Expanding the Role of SABR…
FASTRACK II: Expanding the Role of SABR in Localized Renal Cell Carcinoma
European Urology
·
August 5
Urology & Nephrology
Related Questions
Explore related topics
What is the evidence for SABR in localized renal cell carcinoma?
How does stereotactic ablative radiotherapy compare to surgery or ablation for early-stage kidney cancer?
What are the outcomes of FASTRACK trials for renal cell carcinoma?
Keep scrolling
More content below.
Load next
Up Next
